Showing results (341-350 of 364) with videos related to

Sort By:
Pageof 37
Anticancer Research|January 1, 1982
Treatment of lymphoid neoplasias with interferon. II. Human leucocyte alpha-interferon in chronic lymphatic leukemia (CLL). PHase I-II trialJ L Misset, G Mathé, J Gastiaburu, et al.
The Prostate|January 1, 1986
Phase II trial with D-Trp-6-LH-RH in prostatic carcinoma: comparison with other hormonal agentsG Mathé, A V Schally, A M Comaru-Schally, et al.
La Nouvelle Presse Medicale|December 20, 1975
[Adriamycin, VM 26, cyclophosphamide and prednisone (AVmCP) combination in the therapy of disseminated lymphoreticulosarcoma (Stages or topographical forms III and IV]J L Misset, P Pouillart, J L Amiel, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
Cisplatinumdiamminodichloride (CPDD) in chemotherapy of cancers: a phase II therapeutic trialM Hayat, G Brulé, P Cappelaere, et al.
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|November 1, 1975
Immunoblastic lymphosarcoma, a cytological and clinical entity?G Mathé, D Belpomme, D Dantchev, et al.
Anticancer Research|January 1, 1982
Treatment of lymphoid neoplasias with interferon. I. Human fibroblastic beta-interferon in malignant gammapathies. Phase II trialJ L Misset, G Mathé, J Gastiaburu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1982
[Treatment of leukemias and lymphomas with interferons: I. Trial of myeloma therapy with human beta-interferon]J L Misset, G Mathé, J Gastiaburu, et al.
British Medical Journal|March 24, 1973
Hydroxyurea, leucopheresis, and splenectomy in chronic myeloid leukaemia at the problastic phaseL Schwarzenberg, G Mathé, P Pouillart, et al.
La Nouvelle Presse Medicale|May 3, 1975
[Active immunotherapy of acute leukemia and leukemic lymphosarcoma. Results of 10 years. Study of 200 cases]G Mathé, J L Amiel, L Schwarzenberg, et al.
Cancer Treatment Reports|May 1, 1978
Phase II clinical trial with vindesine for remission induction in acute leukemia, blastic crisis of chronic myeloid leukemia, lymphosarcoma, and hodgkin's disease: absence of cross-resistance with vincristineG Mathé, J L Misset, F De Vassal, et al.
Pageof 37